PRP Treatment Offers Innovative Solutions in Infertility

PRP Treatment Offers Innovative Solutions in Infertility
PRP Treatment Offers Innovative Solutions in Infertility

Regarding the PRP method, also known as ovarian rejuvenation, Gynecology, Obstetrics and IVF Specialist Prof. Dr. Erkut Attar said, “Spontaneous pregnancies occur in early menopause cases that we approach with the PRP method. The method provides an opportunity for the patient to conceive with his own egg and preserve his fertility.”

Pointing out that PRP, which is used in the treatment of many diseases from hair loss to skin rejuvenation, from pain treatment to orthopedic diseases, also offers innovative solutions in the treatment of infertility, Prof. Dr. Erkut Attar said that successful results can be achieved especially in women with early menopause and low egg count.

EARLY MENOPEASE CAN BE SEEN EVEN IN THE 20S

Pointing out that women can enter early menopause from the age of 20 for different reasons, Prof. Dr. Erkut Attar said, “Therefore, if there is no marriage or union, we definitely recommend egg freezing, especially for patients over the age of 35. First of all, it is very important to raise awareness for this situation. Unfortunately, the egg freezing process is delayed in patients because there is not enough information and awareness on this issue. Afterwards, either no eggs can be detected or very few eggs are detected. In these cases, we can achieve successful results with the PRP method.”

PREGNANCY CAN DEVELOP Spontaneously with the PRP METHOD

Yeditepe University Hospitals Gynecology, Obstetrics and IVF Specialist Prof., who stated that he had very good experience in PRP applications. Dr. Attar continued his words as follows: “Spontaneous pregnancies occur in early menopause cases that we approach with the PRP method. Our data also proves that it increases the ovarian reserve. Therefore, it gives women an opportunity to conceive with their own eggs or to preserve their fertility.”

SCIENTIFIC STUDIES CONTINUE

Reminding that the use of PRP on infertility and fertility is still a controversial issue and scientific studies are still continuing, Prof. Dr. Attar expressed his views on the subject as follows: “In both the classical in vitro fertilization method and the microinjection method, which we commonly use today, treatments were carried out at the initial stage without evidence. Therefore, I think it is not right to be criticized and prejudiced in this direction. Moreover, there is currently no other treatment for premature ovarian failure and low ovarian reserve.”

“CHOOSING THE RIGHT PATIENT IS IMPORTANT”

Underlining that PRP cannot be applied to every patient, Prof. Dr. Erkut Attar emphasized the importance of choosing the right patient in order to achieve successful results and continued: “We also apply PRP to patients with advanced age and those with fewer eggs. There are classification systems for low ovarian reserve. Patients with relatively good egg volumes and relatively younger ages are preferred and the application is made. We do not generally apply PRP to those whose egg volumes are very small, the menopause period is very long, and those who are older. Therefore, the results are very good in the patients we applied selectively. We can say that PRP is a complete treatment method in early ovarian failure and patients with reduced egg reserve.”

IT WILL BECOME A ROUTINE METHOD IN FUTURE

Saying that he believes that PRP will become a routine method in in vitro fertilization treatments all over the world in the future, Yeditepe University Hospitals Obstetrics and Gynecology, IVF Specialist Prof. Dr. Erkut Attar said, “There is no problem with its reliability, moreover, it has no visible side effects. We inject PRP into the ovary just as they inject the knee and face. Since the injected cells are mature body cells, it is almost impossible to show any serious side effects. It is also difficult to publish these results due to unnecessary prejudices,” he concluded.

Be the first to comment

Leave a response

Your email address will not be published.


*